|
1. IKEM - Care for patients with particularly severe obesity. 2. Effect of complex intervention aimed at weight reduction and rhythm
control in obese patients with atrial fibrillation. 3. The role of epicardial adipose tissue, subclinical inflammation and
new lipid signaling molecules in the onset and development of heart failure 4. Importance of epicardial adipose tissue in heart disease: new mechanisms of action and their therapeutic influence Grant AZV 15-26854Investigator: prof. MUDr. Martin Haluzík, DrSc., Head of the Diabetology Centre of IKEM in PragueTeam leaders: MUDr. Denisa Haluzíková, Doc. MUDr. Zdeněk Vilikus, CSc. (UTL 1st Faculty of Medicine, Charles University)Duration: 2015-2018 5. Role of gastrointestinal hormones and endocrine dysfunction of intestine in etiopathogenesis of short bowel syndrome Grant AZV 15-27863Investigator: prof. MUDr. Martin Haluzík, DrSc, ÚLBLD 1st Faculty of Medicine, Charles University and General Teaching HospitalsCollaborators: MUDr. Denisa Haluzíková, Doc. MUDr. Zdeněk Vilikus, CSc. (UTL 1st Faculty of Medicine, Charles University)Duration: 2015-2018 6. Pheochromocytoma as a model of chronic activation of the stress axis in the pathogenesis of metabolic disordersGrant AZV 16-30345AHprincipal investigator: MUDr. Ondřej Petrák, PhD., III. IK 1st Faculty of Medicine, Charles University and General Teaching Hospitals: MUDr. Denisa Haluzíková, Doc. MUDr. Zdeněk Vilikus, CSc. (UTL 1st FM UK)Duration: 2016-2019 7. Grant AZV 15-27863A. The role of gastrointestinal hormones and endocrine dysfunction of the intestine in the etiopathogenesis of short bowel syndromeMain investigator: prof. MUDr. Martin Haluzík, DrSc, ÚLBLD 1st Faculty of Medicine, Charles University and General Teaching Hospital: MUDr. Denisa Haluzíková, UTLDoba solution: 2015-2018 8. Grant AZV 15-26854A The importance of epicardial adipose tissue in heart disease: new mechanisms of action and their therapeutic influencePrincipal investigator: prof. MUDr. Martin Haluzík, DrSc , ÚLBLD 1. FM UK and General Teaching HospitalBoth: 2015-2018collaborator: MUDr. 9. Grant AZV 16-30345A Pheochromocytoma as a model of chronic activation of stress axis in the pathogenesis of metabolic disordersDuration: 2015-2018Principal investigator: MUDr. Ondřej Petrák, PhD., III. IKcollaborator: MUDr. Denisa Haluzíková, UTL 10. VFN RVO-VFN64165 Research plan, Diagnosis and treatment of genetically determined disorders within the Development of the VFNHmain investigator: prof. MUDr. Jan Kvasnička, DrSc.Duration: 2012-2017collaborator: MUDr. Denisa Haluzíková, UTL 11. Grant IGA MZ ČR NT 13299-4/ 2012 (2009-2012)Molecular mechanisms of subclinical inflammation in adipose tissue and its contribution to etiopathogenesis of type 2 diabetes mellitus.co-investigator: MUDr. 12. RVO-VFN64165 Research Plan of the General Teaching Hospital (2009-2012)Diagnosis and treatment of genetically determined disorders within the Development of the VFN Research OrganizationCo-investigator: MUDr. Denisa Haluzíková (UTL 1st Faculty of Medicine, Charles University, Salmovská 5, Prague 2) 13. Research project GACR No. 406/09/0647(2009-2012)Possible link between physical fitness, health status and attractiveness in cross-cultural perspectiveinvestigator: Mgr. Jan Havlíček, PhD. (Faculty of Social Studies, U kříže 10, Praha 5)collaborator: Doc. MUDr. Zdeněk Vilikus, CSc. (UTL 1st Faculty of Medicine, Charles University, Salmovská 2, Praha 2) 14. Research plan of MSM 0021620814 (2005-2011)Prevention, diagnostics and therapy of diabetes mellitus, metabolic and endocrine disorders investigator: Prof. MUDr. Michal Anděl, DrSc. (Centre of Preventive Medicine, 3rd Faculty of Medicine, Ruská 87, Pha10)co-investigator: MUDr. Denisa Haluzíková (UTL 1st Faculty of Medicine, Salmovská 5, Praha 2) 15. Diagnostics and treatment of genetically determined disorders II.Research plan of the Ministry of Health of the Czech Republic No. 64165 (2005-2011)investigator: Prof. MUDr. Jan Kvasnička, DrSc. (I. Internal Clinic of the 1st Faculty of Medicine, Charles University, U Nemocnice 1, Pha 2)co-investigator: MUDr. Faculty of Medicine, Salmovská 5, Prague 2) 16. Importance and mechanism of action of adipocytic hormones in regulation of insulin sensitivity in patients with insulin resistance of various etiologiesIGA MZ ČR 8302-5 (2005-2009)investigator: Doc. MUDr. Martin Haluzík, PhD. (III. Internal Clinic of the 1st Faculty of Medicine, Charles University, U Nemocnice 1, Praha 2)co-investigator: MUDr. Denisa Haluzíková (UTL 1st Faculty of Medicine, Charles University, Salmovská 5, Praha 2) 17. Importance of renin-angiotensin system blockade in the treatment of the most common cardiovascular diseasesResearch project of Zentiva company (2005-2008)investigator: Doc. MUDr. Martin Haluzík, PhD. (III. Internal Clinic of the 1st Faculty of Medicine, Charles University, U Nemocnice 1, Praha 2)co-investigator: MUDr. Denisa Haluzíková (UTL 1st Faculty of Medicine, Charles University, Salmovská 2, Praha 2) 18. Prediction of changes in individual parameters of metabolic syndrome based on changes in betahydroxybutyrate as a marker of ketogenesis during interventional studies with physical activity in patients with metabolic syndrome. NR/8384-3 (2005-2007)investigator: MUDr. M. Matoulek, PhD. (III. Internal Clinic of the 1st Faculty of Medicine, Charles University, U Nemocnice 1, Praha 2)co-investigator: Doc. MUDr. Zdeněk Vilikus, CSc. (UTL 1st Faculty of Medicine, Charles University, Salmovská 5, Praha 2) 19. Importance of PPAR in regulation of insulin sensitivityIGA MZ ČR NR/7429-3 (2003-2005)INVESTIGATOR: Doc. MUDr. M. Haluzík, PhD. (III. Internal Clinic of the 1st Faculty of Medicine, Charles University, U Nemocnice 1, Praha 2)co-investigator: MUDr. Denisa Haluzíková, CSc. (UTL 1st Faculty of Medicine, Charles University, Salmovská 5, Praha 2) 20. Fatigue in patients with multiple sclerosis – limit of load or therapeutically modifiable symptom. Prescription zátěže.GA UK No. 1641/2002-IV (2002-2005)investigator: PhDr. Kamila Řasová (Department of Neurology, 1st Faculty of Medicine, Charles University, Kateřinská 32, Praha 2)co-investigator: Doc. MUDr. Petr Brandejský, CSc. (UTL 1st Faculty of Medicine, Charles University, Salmovská 5, Praha 2) |